SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Edscharp who wrote (886)7/13/1999 6:08:00 PM
From: JEB  Respond to of 2515
 
It may not be that long of a wait if they get the fast-track FDA approval for C225 on pancreatic cancer. Preliminary data shows real promise there.



To: Edscharp who wrote (886)7/13/1999 7:19:00 PM
From: Jane4IceCream  Read Replies (5) | Respond to of 2515
 
Another dedicated shorter (Anthony @Pacific) is also very long on Imclone.

I have been long since the 11's, 13's, and again in the 18's and 19's and not selling a single share.

Imclone is my sanity in this turbulent stock market.

Jane:-)



To: Edscharp who wrote (886)7/13/1999 7:59:00 PM
From: Dr. Seuss  Read Replies (1) | Respond to of 2515
 
Dedicated money maker (not just short)....just better at the short game. IMCL (at this stage) is a no brainer.

Dr. Seuss



To: Edscharp who wrote (886)7/18/1999 6:56:00 PM
From: Michael T Currie  Respond to of 2515
 
> I am a bit surprised to see a dedicated shorter investing in Imclone.

Well, you can count me in as well. 75% of my trading is short.

Mike


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News